Skip to content

A Retrospective Study of COVID-19 Treatments

A Retrospective Study to Analyze Efficacy of COVID-19 Treatments

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04949230
Enrollment
300
Registered
2021-07-02
Start date
2021-02-19
Completion date
2024-02-15
Last updated
2024-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, COVID-19 Acute Bronchitis, COVID-19 Acute Respiratory Distress Syndrome, COVID-19 Lower Respiratory Infection, COVID-19 Pneumonia, COVID-19 Respiratory Infection, SARS-CoV-2 Acute Respiratory Disease, SARS-CoV2 Infection

Brief summary

Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.

Detailed description

Subjects who have recovered from COVID-19 will answer questions regarding the severity of their illness, symptoms experienced, what treatment they received, and how long they were ill.

Interventions

There is no intervention in this study

Sponsors

ProgenaBiome
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Months to No maximum
Healthy volunteers
No

Inclusion criteria

1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study 2. Male or female of 18 years of age or older 3. Diagnosis of COVID-19 infection by RT- PCR 4. Recovery from COVID-19

Design outcomes

Primary

MeasureTime frameDescription
Survey ResponseOne hourAnswers given by subjects on their recovery from COVID-19

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026